This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Study in Healthy Adults of the Safety, Tolerabil...
Clinical trial

A Study in Healthy Adults of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process

Read time: 1 mins
Last updated:23rd Nov 2006
To describe the seroprotection rate (SPR) one month after the third dose of vaccine for a modified process hepatitis B vaccine in healthy adults (?50 years of age).
Category Value
Study start date 2006-11-23

View full details